3P Biopharmaceuticals initiates partnership with American Biotech Zhittya for Parkinson’s disease treatment

Monday October 21st, 2019 | General

3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, and the American biotech company, Zhittya Genesis Medicine (Zhittya), have successfully accomplished a tech transfer. 3P and Zhittya began their relationship at the beginning of 2019 with 3P being selected as the CDMO to transfer […]

3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

Thursday June 6th, 2019 | General

The arrangement covers process transfer, process development and GMP manufacture of Affibody’s candidate 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Swedish company Affibody for the process transfer, scale-up and GMP commercial manufacturing of a recombinant protein sole property of Affibody. […]